Chris_Halkides
Penultimate Amazing
- Joined
- Dec 8, 2009
- Messages
- 13,028
At SBM David Gorski wrote, "...let’s take a look at the commentary, as well as some recent evidence regarding the premature termination of clinical trials, thanks to this administration’s unprecedented premature termination of large numbers of NIH grants for nonscientific—indeed, explicitly ideological—reasons. Understand, too, that nothing like this has ever been done before; no prior administration, even conservative Republican administrations, has mass-canceled large numbers of scientific grants funded by the NIH for any reason, much less explicitly ideological reasons...The authors argue that canceling a clinical trial for ideological reasons is also unethical, and I couldn’t agree more. For instance, the reference cited above (#4) is to a Science news article on clinical trials in underdeveloped countries that were canceled by USAID cuts. These trials included tests of two experimental HIV vaccines, trials of interventions to prevent and treat malaria, and a test of whether appropriate interventions of hydration could prevent chronic kidney disease in impoverished workers. Granted, these were not NIH-funded trials, but trials funded by USAID; however, the toll on NIH-funded clinical research has also been grim, and the authors cite a study from late last year that documented the carnage..."
He continued, "However, they do note that we know that premature termination of NIH grants was “rare” prior to 2025, which jibes with my experience and observations throughout my career dating back to the 1990s, also noting that, because “trials require sustained financial support to ensure operations and participant safety, unanticipated funding disruptions raise concerns about avoidable waste, data quality, and compromised ethical obligations to participants.” No kidding. It’s the stupidest, most short-sighted way to deal with clinical trials ever, as premature termination often renders clinical trials, at best, less rigorous and reliable because it compromises clinical trial accrual, treatment, and/or followup, or, at worst, renders the data from the trial utterly unusable, meaning that what had been spent on the trial before termination was utterly wasted. Then there’s another issue. Once a grant is canceled, it’s often difficult or impossible to restart the research even if the cancellation is reversed."
He continued, "However, they do note that we know that premature termination of NIH grants was “rare” prior to 2025, which jibes with my experience and observations throughout my career dating back to the 1990s, also noting that, because “trials require sustained financial support to ensure operations and participant safety, unanticipated funding disruptions raise concerns about avoidable waste, data quality, and compromised ethical obligations to participants.” No kidding. It’s the stupidest, most short-sighted way to deal with clinical trials ever, as premature termination often renders clinical trials, at best, less rigorous and reliable because it compromises clinical trial accrual, treatment, and/or followup, or, at worst, renders the data from the trial utterly unusable, meaning that what had been spent on the trial before termination was utterly wasted. Then there’s another issue. Once a grant is canceled, it’s often difficult or impossible to restart the research even if the cancellation is reversed."